Visudyne - direct healthcare professional communication (DHPC)

verteporfin

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Visudyne (verteporfin): Information on the continuing supply restriction until end Q1/2022

Key facts

• Medicine name:
  Visudyne
• Active substance:
  verteporfin
• Therapeutic area (MeSH):
  • Myopia, Degenerative
  • Macular Degeneration
• DHPC type:
  Medicine shortage
• Human ATC codes:
  S01LA01
• Dissemination date:
  05/11/2021